How a cocktail of existing drugs could regenerate insulin-producing cells in diabetes

No diabetes drug can tackle the underlying cause of the disease. Scientists at the Icahn School of Medicine at Mount Sinai hope to change that. They found adding an existing medicine to popular GLP-1 receptor agonists can regenerate insulin-producing beta cells at high rates in both lab dishes and mice.